Business Description
Vivani Medical Inc
NAICS : 541714
SIC : 2833
ISIN : US92854B1098
Total Employee Number:
36Description
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.08 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.96 | |||||
Debt-to-EBITDA | -0.67 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 7.2 | |||||
3-Year EPS without NRI Growth Rate | -6.1 | |||||
3-Year FCF Growth Rate | 6.5 | |||||
3-Year Book Growth Rate | -38.2 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 31.74 | |||||
9-Day RSI | 42.2 | |||||
14-Day RSI | 46.77 | |||||
3-1 Month Momentum % | -9.63 | |||||
6-1 Month Momentum % | -17.57 | |||||
12-1 Month Momentum % | -23.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.18 | |||||
Quick Ratio | 3.18 | |||||
Cash Ratio | 2.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.6 | |||||
Shareholder Yield % | -8.01 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -257.2 | |||||
ROA % | -79.13 | |||||
ROIC % | -122.69 | |||||
3-Year ROIIC % | -34.25 | |||||
ROC (Joel Greenblatt) % | -143.61 | |||||
ROCE % | -100.76 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 5.69 | |||||
Price-to-Tangible-Book | 5.57 | |||||
EV-to-EBIT | -3.92 | |||||
EV-to-Forward-EBIT | -2.56 | |||||
EV-to-EBITDA | -3.98 | |||||
EV-to-FCF | -4.11 | |||||
Earnings Yield (Greenblatt) % | -25.51 | |||||
FCF Yield % | -24.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VANI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vivani Medical Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.4 | ||
| Beta | 4.1268 | ||
| 3-Year Sharpe Ratio | 0.38 | ||
| 3-Year Sortino Ratio | 1.6 | ||
| Volatility % | 58.13 | ||
| 14-Day RSI | 46.77 | ||
| 14-Day ATR ($) | 0.103959 | ||
| 20-Day SMA ($) | 1.3525 | ||
| 12-1 Month Momentum % | -23.75 | ||
| 52-Week Range ($) | 0.92275 - 1.92 | ||
| Shares Outstanding (Mil) | 86.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vivani Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vivani Medical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 110 days | ||
| Second quarter earnings results for 2026 | 2026-08-13 | In 18 days | ||
| 94th Emerging Growth Conference | 2026-07-15 16:10 | 1.40 (+0.00%) | ||
| General meeting for 2026 | 2026-06-24 10:00 | 1.19 (+4.39%) | ||
| Jefferies Global Healthcare Conference | 2026-06-04 11:05 | 1.28 (-2.29%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 1.14 (-5.00%) | ||
| Annual report for 2025 | 2026-03-26 | 1.13 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-26 | 1.13 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-13 | 1.53 (+6.25%) | ||
| Guidance call for 2025 | 2025-10-30 13:30 | 1.77 (+1.72%) |
Show
Entries
Vivani Medical Inc Frequently Asked Questions
What is Vivani Medical Inc(VANI)'s stock price today?
The current price of VANI is $1.28. The 52 week high of VANI is $1.92 and 52 week low is $0.92.
When is next earnings date of Vivani Medical Inc(VANI)?
The next earnings date of Vivani Medical Inc(VANI) is 2026-08-13 Est..
Does Vivani Medical Inc(VANI) pay dividends? If so, how much?
Vivani Medical Inc(VANI) does not pay dividend.
Guru Commentaries on NAS:VANI
No articles.
Press Release
Articles on Vivani Medical Inc
Market Today: Netflix Drops, Uber Buys Delivery Hero, Visa Launches Stablecoin Platform
Jul 16, 2026
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers